Conference · Boston, Massachusetts
Antibodies for Cancer Therapy Conference 2011
Health · Medicine · Pharmaceuticals
Key numbers
- Editions on record
- 5first in 2011
About Antibodies for Cancer Therapy Conference
KEYNOTE PRESENTATIONS
Chairperson’s Opening Remarks 8:40 Antibodies for Cancer: Past, Present and Future
Janice Reichert, Ph.D., Research Assistant Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
The majority of development programs for monoclonal antibodies have focused on cancer, resulting in nearly a dozen marketed products and a variety of novel antibody modalities in clinical study. An overview of development and approval trends for novel anti-cancer mAbs, including bispecific antibodies and antibody-drug conjugates, will be discussed.
Kymouse Platform to Generate Highly Selective, Potent and Well-Tolerated Human Antibody-Based Biopharmaceuticals
Sphingosine-1-Phosphate Antibodies as Potential Agents in the Treatment of Cancer and Age-Related Macular Degeneration
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2015 | 29–30 Apr 2015 | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2014 | 5–6 May 2014 | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2013 | 29–30 Apr 2013 | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2012 | 30 Apr – 1 May 2012 | Boston Park Plaza Hotel Boston, Massachusetts | — | — |
| 2011 | 9–10 May 2011 | Sheraton Boston Hotel & Towers Boston, Massachusetts | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.